Found: 107
Select item for more details and to access through your institution.
Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer's disease.
- Published in:
- Molecular Medicine, 2020, v. 26, n. 1, p. 1, doi. 10.1186/s10020-020-00163-5
- By:
- Publication type:
- Article
The Role of Macrophage Migration Inhibitory Factor in Alzheimer's Disease.
- Published in:
- Molecular Medicine, 2010, v. 16, n. 3/4, p. 116, doi. 10.2119/molmed.2009.00123
- By:
- Publication type:
- Article
Association of N-Acetylaspartate and Cerebrospinal Fluid Aβ<sub>42</sub> in Dementia.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 27, n. 2, p. 393, doi. 10.3233/JAD-2011-110398
- By:
- Publication type:
- Article
Cerebrospinal Fluid Markers for Alzheimer's Disease over the Lifespan: Effects of Age and the APOEℇ4 Genotype.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 22, n. 2, p. 459, doi. 10.3233/JAD-2010-100561
- By:
- Publication type:
- Article
Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Measurement of ERK 1/2 in CSF from Patients with Neuropsychiatric Disorders and Evidence for the Presence of the Activated Form.
- Published in:
- Journal of Alzheimer's Disease, 2009, v. 18, n. 3, p. 613, doi. 10.3233/JAD-2009-1167
- By:
- Publication type:
- Article
Cerebrospinal Fluid Proteome Alterations Associated with Neuropsychiatric Symptoms in Cognitive Decline and Alzheimer's Disease.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 6, p. 1030, doi. 10.3390/cells11061030
- By:
- Publication type:
- Article
Persisting neuropsychiatric symptoms, Alzheimer's disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01139-9
- By:
- Publication type:
- Article
An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00814-7
- By:
- Publication type:
- Article
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00805-8
- By:
- Publication type:
- Article
Association between Serum Phytosterols and Lipid Levels in a Population-Based Study.
- Published in:
- Nutrients, 2024, v. 16, n. 6, p. 775, doi. 10.3390/nu16060775
- By:
- Publication type:
- Article
Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease.
- Published in:
- Journal of Neurochemistry, 2012, v. 123, n. 2, p. 310, doi. 10.1111/j.1471-4159.2012.07893.x
- By:
- Publication type:
- Article
SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease.
- Published in:
- Human Molecular Genetics, 2014, v. 23, n. 24, p. 6644
- By:
- Publication type:
- Article
One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0270-x
- By:
- Publication type:
- Article
Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer's disease pathology modulates cognitive performance.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0235-0
- By:
- Publication type:
- Article
Determinants of the essential one-carbon metabolism metabolites, homocysteine, S-adenosylmethionine, S-adenosylhomocysteine and folate, in cerebrospinal fluid.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2012, v. 50, n. 9, p. 1641, doi. 10.1515/cclm-2012-0056
- By:
- Publication type:
- Article
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
- Published in:
- 2020
- By:
- Publication type:
- journal article
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment.
- Published in:
- Acta Neuropathologica, 2020, v. 139, n. 6, p. 1025, doi. 10.1007/s00401-020-02138-6
- By:
- Publication type:
- Article
CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism
- Published in:
- European Psychiatry, 2009, v. 24, n. 3, p. 183, doi. 10.1016/j.eurpsy.2008.12.005
- By:
- Publication type:
- Article
Biomarker in der Diagnostik kognitiver Störungen – Empfehlungen der Swiss Memory Clinics.
- Published in:
- Praxis (16618157), 2022, v. 111, n. 13, p. 738, doi. 10.1024/1661-8157/a003913
- By:
- Publication type:
- Article
Empfehlungen für die Prävention, Diagnostik und Therapie der Abhängigkeitserkrankungen im Alter.
- Published in:
- Praxis (16618157), 2022, v. 111, n. 2, p. 79, doi. 10.1024/1661-8157/a003609
- By:
- Publication type:
- Article
Empfehlungen für die Diagnostik und Therapie psychotischer Erkrankungen im Alter.
- Published in:
- Praxis (16618157), 2021, v. 110, n. 14, p. 816, doi. 10.1024/1661-8157/a003748
- By:
- Publication type:
- Article
Empfehlungen für die Prävention, Diagnostik und Therapie der Abhängigkeitserkrankungen im Alter.
- Published in:
- Praxis (16618157), 2021, v. 110, n. 2, p. 79, doi. 10.1024/1661-8157/a003609
- By:
- Publication type:
- Article
Die Empfehlungen der Swiss CS Memory Clinics für die Diagnostik der Demenzerkrankungen.
- Published in:
- Praxis (16618157), 2018, v. 107, n. 8, p. 435, doi. 10.1024/1661-8157/a002948
- By:
- Publication type:
- Article
Empfehlungen zur Prävention, Diagnostik und Therapie des Delirs im Alter.
- Published in:
- Praxis (16618157), 2016, v. 105, n. 16, p. 941, doi. 10.1024/1661-8157/a002433
- By:
- Publication type:
- Article
S-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
- Published in:
- Neurodegenerative Diseases, 2010, v. 7, n. 6, p. 373, doi. 10.1159/000309657
- By:
- Publication type:
- Article
Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12286
- By:
- Publication type:
- Article
CSF proteomic profiling of mild cognitive impairment individuals with suspected non‐Alzheimer's disease pathophysiology: Developing topics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.047247
- By:
- Publication type:
- Article
Synaptic proteins relate to memory scores in preclinical Alzheimer's disease and cognitively healthy controls depending on amyloid: Molecular and cell biology/synaptic disruption.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046102
- By:
- Publication type:
- Article
DNA methylation differences associated with peripheral biomarkers in the EMIF‐AD cohort: Biomarkers (non‐neuroimaging) / Novel biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045853
- By:
- Publication type:
- Article
Neurofilament light and cognitive performance: Associations with amyloid and vascular pathologies in individuals with mild cognitive impairment: Biomarkers (non‐neuroimaging): EEG and other biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042739
- By:
- Publication type:
- Article
Determinants of subjective cognitive decline in dementia‐free older adults: A population‐based study: Neuropsychology/Early detection of cognitive decline with neuropsychological tests.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.038805
- By:
- Publication type:
- Article
An integrative, hypothesis‐free, multi‐omics approach uncovers biological pathway alterations in Alzheimer's disease: Development of new models and analysis methods/novel assays and technologies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.038563
- By:
- Publication type:
- Article
O5‐05‐03: ASSOCIATIONS BETWEEN CEREBROSPINAL FLUID NEURODEGENERATIVE MARKERS, NEUROFILAMENT‐LIGHT AND TOTAL TAU AND CEREBROVASCULAR IMAGING MARKERS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1626, doi. 10.1016/j.jalz.2019.06.4860
- By:
- Publication type:
- Article
P4‐525: ASSOCIATION OF CSF TAU WITH HYPERPLASTICITY IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1515, doi. 10.1016/j.jalz.2019.08.072
- By:
- Publication type:
- Article
P2‐242: PATHOPHYSIOLOGICAL SUBTYPES OF ALZHEIMER'S DISEASE BASED ON CEREBROSPINAL FLUID PROTEOMICS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P675, doi. 10.1016/j.jalz.2019.06.2649
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 5, p. 644, doi. 10.1016/j.jalz.2019.01.004
- By:
- Publication type:
- Article
Blood‐brain barrier breakdown, neuroinflammation, and cognitive decline in older adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 12, p. 1640, doi. 10.1016/j.jalz.2018.06.2857
- By:
- Publication type:
- Article
P4‐193: IDENTIFICATION AND COMPREHENSIVE CHARACTERIZATION OF CNS AND SYSTEMIC METABOLIC ALTERATIONS IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1513, doi. 10.1016/j.jalz.2018.06.2598
- By:
- Publication type:
- Article
P3‐418: INTEGRATIVE PREDICTION OF COGNITIVE DECLINE USING ATROPHY NETWORKS, CSF BIOMARKERS, AND GENOTYPE DATA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1267, doi. 10.1016/j.jalz.2018.06.1781
- By:
- Publication type:
- Article
P3‐233: PLASMA PRIMARY FATTY AMIDES ASSOCIATE TO CSF AMYLOID LEVELS AND ALZHEIMER'S DISEASE PROGRESSION IN THE EMIF‐AD BIOMARKER DISCOVERY COHORT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1161, doi. 10.1016/j.jalz.2018.06.1592
- By:
- Publication type:
- Article
P2‐608: SALIVARY CORTISOL AND 5Y CHANGE IN COGNITIVE FUNCTION IN COMMUNITY DWELLING, COGNITIVELY HEALTHY OLDER ADULTS: THE PSYCOLAUS COHORT STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P972, doi. 10.1016/j.jalz.2018.06.1304
- By:
- Publication type:
- Article
P2‐458: PREDICTING COGNITIVE DECLINE THROUGH STRUCTURAL MRI BIOMARKERS: RESULTS FROM THE EMIF‐AD BIOMARKER DISCOVERY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P895, doi. 10.1016/j.jalz.2018.06.1151
- By:
- Publication type:
- Article
P2‐270: INCREASED CSF AMYLOID‐β 1‐38 AND 1‐40 CONCENTRATIONS IN INDIVIDUALS WITH MILD COGNITIVE IMPAIRMENT WITH TAU BUT WITHOUT AMYLOID PATHOPHYSIOLOGY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P780, doi. 10.1016/j.jalz.2018.06.959
- By:
- Publication type:
- Article
F1‐02‐04: GENOMICS AND EPIGENOMICS ANALYSES IN THE EMIF‐AD MULTIMODAL BIOMARKER DISCOVERY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P204, doi. 10.1016/j.jalz.2018.06.2310
- By:
- Publication type:
- Article
F1‐02‐03: MRI PREDICTORS OF AMYLOID PATHOLOGY: RESULTS FROM THE EMIF‐AD BIOMARKER DISCOVERY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P202, doi. 10.1016/j.jalz.2018.06.2309
- By:
- Publication type:
- Article
F1‐02‐01: RELATING CSF MARKERS NEUROGRANIN, NEUROFILAMENT‐LIGHT AND YKL‐40 TO Aβ, APOE ε4 AND COGNITION: RESULTS FROM THE EMIF‐AD MULTIMODAL BIOMARKER DISCOVERY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P201, doi. 10.1016/j.jalz.2018.06.2307
- By:
- Publication type:
- Article
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 7, p. 913, doi. 10.1016/j.jalz.2018.02.009
- By:
- Publication type:
- Article
ONE-CARBON METABOLISM, COGNITIVE IMPAIRMENT AND CSF MARKERS OF ALZHEIMER PATHOLOGY: HOMOCYSTEINE AND BEYOND.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P705, doi. 10.1016/j.jalz.2017.06.896
- By:
- Publication type:
- Article
DISCOVERY, REPLICATION AND EXTENSION STUDY OF PLASMA PROTEOMIC BIOMARKERS RELATING TO BRAIN AMYLOID BURDEN (CSF Aβ OR AMYLOID-PET) IN THE EMIF-AD BIOMARKER DISCOVERY COHORT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P361, doi. 10.1016/j.jalz.2017.06.305
- By:
- Publication type:
- Article